Evidence map›Paper›PMID 40385268›Full record

ArticleCardiovascular diagnosis and therapy2025

Investigating the causal relationship between genetically determined metabolites and ischemic stroke functional outcomes: a Mendelian randomization study.

Xiaobei Zhang, Gehong Liang, Ying Zheng, Xiaokun Wang, Weihao Luo, Guiyue Wang, Yiqing Yin

Abstract read
In one paragraph

Article in Cardiovascular diagnosis and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaobei Zhang *Department of Anesthesiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.ORCID https://orcid.org/0000-0002-9244-5669
Gehong Liang *Department of Infectious Diseases and Immunology, The Second Hospital of Tianjin Medical University, Tianjin, China.ORCID https://orcid.org/0009-0000-3222-7013
Ying ZhengDepartment of Anesthesiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.ORCID https://orcid.org/0000-0002-5264-6431
Xiaokun WangDepartment of Anesthesiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.ORCID https://orcid.org/0000-0002-7174-2007
Weihao LuoDepartment of Anesthesiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.ORCID https://orcid.org/0000-0002-5922-969X
Guiyue WangDepartment of Anesthesiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.ORCID https://orcid.org/0000-0002-9761-7343
Yiqing YinDepartment of Anesthesiology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.ORCID https://orcid.org/0000-0002-1130-6676

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ischemic stroke functional outcomes are critical determinants of recovery quality; however, our understanding of the underlying metabolic influences remains incomplete. Mendelian randomization (MR) is ideal for inferring causal links between metabolites and ischemic stroke outcomes by using genetic variants to reduce confounding and reverse causality. This study explored the causal relationships between genetically determined metabolites and functional recovery after stroke. Methods: In this study, we employed a two-sample MR framework to investigate the influence of plasma metabolites on ischemic stroke functional outcomes. We analyzed outcome data derived from a comprehensive genome-wide association study (GWAS) that included 6,165 stroke patients. The baseline group data were adjusted for ancestry, age, sex, and ischemic stroke severity using the National Institutes of Health Stroke Scale (NIHSS). The primary outcome was 3-month dependence or death defined as a modified Rankin Scale (mRS) of 3-6. The exposures consisted of a comprehensive set of 1,400 metabolites and instrumental variables (IVs) that exhibited strong genetic associations with minimal indications of pleiotropic effects were selected. IVs are selected based on genomic significance level P<1×10 Results: Using the IVW method, our study identified 59 metabolites with potentially causal relationships to ischemic stroke functional outcomes. Notably, the positive causal link between X-17146 and ischemic stroke functional outcomes, which had an odds ratio (OR) of 0.48 [95% confidence interval (CI): 0.35-0.68, P<0.001], remained significant even after applying false discovery rate (FDR) corrections (P Conclusions: Our findings suggest that specific metabolites have a causative impact on the functional recovery process ischemic stroke, and provide a foundation for further research into personalized treatment strategies that address these metabolic pathways. Future studies should aim to validate these results using diverse population samples and experimental models to enhance the clinical applicability of the findings.

Indexed as

functional outcomeMendelian randomization (MR)metabolomicsStroke

Identifiers

PMID40385268
PMCPMC12082180

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.